Chronic inflammation with the presence of excess serum acute-phase proteins, cytokines and cell adhesion molecules is increasingly being implicated in atherosclerosis. The association between inflammatory bowel disease (IBD) and coronary artery disease (CAD) is unstudied. This is a preliminary, thesis-generating cross-sectional study aimed at evaluating the presence of traditional atherosclerotic risk factors in patients with IBD and CAD compared with the control population. The medical records of 42 consecutive IBD patients with CAD from 1999 to 2005 (27 men) were reviewed for the Framingham risk factors. The Framingham risk score (FRS) is calculated based on age, sex, hypertension, diabetes and hyperlipidemia. FRS of patients with IBD and CAD was compared with the FRS of 137 age- and sex-matched (102 men) consecutive patients with CAD (controls). When the Framingham risk score adjusted for group and gender with age as a covariate, the adjusted total FRS score was higher in patients with CAD alone (10.0 [3.75]) as compared to those with; IBD and CAD: (8.1 [3.47]; p = 0.001). FRS is lower in cases (patients with IBD and CAD) when compared with the controls (CAD alone).
Framingham Heart Study Multivariate models Pathogenesis of atherosclerosis
This is a preview of subscription content, log in to check access.
Zoccali C, Mallamaci F, Tripepi G. Inflammatory proteins as predictors of cardiovascular disease in patients with end-stage renal disease. Nephrol Dial Transplant 2004;19(suppl. 5):67–72.CrossRefGoogle Scholar
Shovman O, Gilburd B, Shoenfeld Y. The role of inflammatory cytokines in the pathogenesis of sytemic Lupus erythematosus-related atherosclerosis: a novel target for treatment. J Rheumatol 2006;33:445–447.PubMedGoogle Scholar
Deliargyris EN, Madianos PN, Kadoma W, et al. Periodontal disease in patients with acute myocardial infarction: prevalence and contribution to elevated C-reactive protein levels. Am Heart J 2004;147:1005–1009.PubMedCrossRefGoogle Scholar
Goggins MG, Goh J, O’Connell MA, et al. Soluble adhesion molecules in inflammatory bowel disease. Ir J Med Sci 2001;170:107–111.PubMedCrossRefGoogle Scholar
Wilson PWF. Assessing coronary heart disease risk with traditional and novel risk factors. Clin Cardiol 2004;27(suppl. III):III-7–III-11.Google Scholar
Ridker PM, Wilson PWF, Grundy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 2004;109:2818–2825.PubMedCrossRefGoogle Scholar
Cucino C, Sonnenberg A. Cause of death in patients with inflammatory bowel disease. Inflamm Bowel Dis 2001;7:250–255.PubMedCrossRefGoogle Scholar
Kupcova V, Turecky L, Detkova Z, et al. Changes in acute phase proteins after anti-tumor necrosis factor antibody (infliximab) treatment in patients with Crohn’s disease. Physiol Res 2003;52:89–93.PubMedGoogle Scholar